KSHV/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states

American Journal of Surgical Pathology

Volumn 37, Issue 2, 2013, Pages 241-249

  Alexanian, Serge ^a   Said, Jonathan ^a   Lones, Mark ^a   Pullarkat, Sheeja T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

body cavity lymphoma; effusion lymphoma; HHV8 KSHV unrelated lymphoma; KSHV HHV8 associated lymphoma; PEL like lymphoma; primary effusion lymphoma

Indexed keywords

CD20 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CASE REPORT; FATALITY; FEMALE; HUMAN; HUMAN HERPESVIRUS 8; ISOLATION AND PURIFICATION; KAPOSI SARCOMA; MALE; METABOLIC DISORDER; METABOLISM; MIDDLE AGED; PATHOLOGY; PRIMARY EFFUSION LYMPHOMA; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD20; FATAL OUTCOME; FEMALE; HERPESVIRUS 8, HUMAN; HUMANS; LYMPHOMA, PRIMARY EFFUSION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SARCOMA, KAPOSI; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; WATER-ELECTROLYTE IMBALANCE;

EID: 84872868075     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318267fabc     Document Type: Article

References (44)

1. Said J, Cesarman E. Primary effusion lymphoma. In: Swerdlow S, Campo E, Harris N, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC WHO Classification of Tumours; 2008:260-261.
2. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood. 1996;88:645-656.
3. Hermine O, Michel M, Buzyn-Veil A, et al. Body-cavity-based lymphoma in an HIV-seronegative patient without Kaposi's sarcoma-associated herpesvirus-like DNA sequences. N Engl J Med. 1996;334:272-273.
4. Carbone A, Gloghini A, Vaccher E, et al. Kaposi's sarcomaassociated herpesvirus DNA sequences in AIDS-related and AIDSunrelated lymphomatous effusions. Br J Haematol. 1996;94: 533-543.
5. Ichinohasama R, Miura I, Kobayashi N, et al. Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature. Am J Surg Pathol. 1998;22:1528-1537.
6. Rodriguez J, Romaguera JE, Katz RL, et al. Primary effusion lymphoma in an HIV-negative patient with no serologic evidence of Kaposi's sarcoma virus. Leuk Lymphoma. 2001;85:185-189.
7. Ashihara E, Shimazaki C, Hirai H, et al. Human herpes virus 8-negative primary effusion lymphoma in a patient with a ventriculoperitoneal shunt tube. Int J Hematol. 2001;74:327-332.
8. Hara T, Nishi S, Horimoto A, et al. Primary effusion lymphoma in a patient with hepatitis C virus-related liver cirrhosis. J Gastroenterol Hepatol. 2001;16:948-949.
9. Yamamoto Y, Kitajima H, Sakihana H, et al. CD3+CD4-CD8-TCR-alphabeta+ T-cell lymphoma with clinical features of primary effusion lymphoma: an autopsy case. Int J Hematol. 2001;74: 442-446.
10. Ohori NP, Whisnant RE, Nalesnik MA, et al. Primary pleural effusion posttransplant lymphoproliferative disorder: distinction from secondary involvement and effusion lymphoma. Diagn Cytopathol. 2001;25:50-53.
11. Saiki M, Saitoh T, Inoue M, et al. Human herpesvirus-8 negative primary effusion lymphoma with complete clinical remission after removal of ascites. Rinsho Ketsueki. 2002;43:548-553.
12. Ohshima K, Ishiguro M, Yamasaki S, et al. Chromosomal and comparative genomic analyses of HHV-8-negative primary effusion lymphoma in five HIV-negative Japanese patients. Leuk Lymphoma. 2002;43:595-601.
13. Paner GP, Jensen J, Foreman K, et al. HIV and HHV-8 negative primary effusion lymphoma in a patient with hepatitis C virusrelated liver cirrhosis. Leuk Lymphoma. 2003;44:1811-1814.
14. Hisamoto A, Yamane H, Hiraki A, et al. Human herpes virus-8-negative primary effusion lymphoma in a patient with common variable immunodeficiency. Leuk Lymphoma. 2003;44:2019-2022.
15. Shimazaki M, Fujita M, Tsukamoto K, et al. An unusual case of primary effusion lymphoma in a HIV-negative patient not pathogenetically associated with HHV8. Eur J Haematol. 2003;71: 62-67.
16. Nakamura Y, Tajima F, Omura H, et al. Primary effusion lymphoma of the left scrotum. Intern Med. 2003;42:351-353.
17. Chiba H, Matsunaga T, Kuribayashi K, et al. Autoimmune hemolytic anemia as a first manifestation of primary effusion lymphoma. Ann Hematol. 2003;82:773-776.
18. Inoue Y, Tsukasaki K, Nagai K, et al. Durable remission by sobuzoxane in an HIV-seronegative patient with human herpesvirus 8-negative primary effusion lymphoma. Int J Hematol. 2004;79: 271-275.
19. Takao T, Kobayashi Y, Kuroda J, et al. Rituximab is effective for human herpesvirus-8-negative primary effusion lymphoma with CD20 phenotype associated hepatitis C virus-related liver cirrhosis. Am J Hematol. 2004;77:419-420.
20. Nonami A, Yokoyama T, Takeshita M, et al. Human herpes virus 8-negative primary effusion lymphoma (PEL) in a patient after repeated chylous ascites and chylothorax. Intern Med. 2004;43: 236-242.
21. Fujiwara T, Ichinohasama R, Miura I, et al. Primary effusion lymphoma of the pericardial cavity carrying t(1;22)(q21;q11) and t(14;17)(q32;q23). Cancer Genet Cytogenet. 2005;156:49-53.
22. Jenkins C, Sorour Y, Blake E, et al. Human-immunodeficiencyvirus- negative, human-herpes-virus-8-negative abdominal cavity primary effusion lymphoma. Clin Oncol (R Coll Radiol). 2005;17: 636-638.
23. Matsumoto Y, Nomura K, Ueda K, et al. Human herpesvirus 8-negative malignant effusion lymphoma: a distinct clinical entity and successful treatment with rituximab. Leuk Lymphoma. 2005; 46:415-419.
24. Venizelos I, Tamiolakis D, Lambropoulou M, et al. An unusual case of posttransplant peritoneal primary effusion lymphoma with T-cell phenotype in a HIV-negative female, not associated with HHV-8. Pathol Oncol Res. 2005;11:178-181.
25. Youngster I, Vaisben E, Cohen H, et al. An unusual cause of pleural effusion. Age Ageing. 2006;35:94-96.
26. Terasaki Y, Okumura H, Saito K, et al. HHV-8/KSHV-negative and CD20-positive primary effusion lymphoma successfully treated by pleural drainage followed by chemotherapy containing rituximab. Intern Med. 2008;47:2175-2178.
27. Niino D, Tsukasaki K, Torii K, et al. Human herpes virus 8-negative primary effusion lymphoma with BCL6 rearrangement in a patient with idiopathic CD4 positive T-lymphocytopenia. Haematologica. 2008;93:21-23.
28. Adiguzel C, Bozkurt SU, Kaygusuz I, et al. Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: report of a rare case and review of the literature. APMIS. 2009;117:222-229.
29. Tsagarakis NJ, Argyrou A, Gortzolidis G, et al. Report of an HIV and HHV-8 negative case of primary effusion lymphoma with idiopathic T4 lymphocytopenia. Int J Hematol. 2009;90:94-98.
30. De Filippi R, Iaccarino G, Frigeri F, et al. Elevation of clonal serum free light chains in patients with HIV-negative primary effusion lymphoma (PEL) and PEL-like lymphoma. Br J Haematol. 2009; 147:405-408.
31. Taira T, Nagasaki A, Okudaira T, et al. HIV-and HHV-8-negative primary effusion lymphoma-like lymphoma presenting with lymphomatous effusions complicated by cardiac tamponade-a case report. Gan To Kagaku Ryoho. 2009;36:1195-1198.
32. Takahashi T, Hangaishi A, Yamamoto G, et al. HIV-negative, HHV-8-unrelated primary effusion lymphoma-like lymphoma: report of two cases. Am J Hematol. 2010;85:85-87.
33. Cooper AR, Burack WR, Allerton JP. A case of Kaposi sarcomaassociated herpesvirus/human herpesvirus 8-unrelated but Epstein-Barr virus-positive primary effusion lymphoma-like lymphoma in the setting of human immunodeficiency virus and hepatitis C virus infection. Leuk Lymphoma. 2010;51:2303-2305.
34. Kagoya Y, Takahashi T, Yoshimoto T, et al. Recurrent pericardial effusion after treatment for primary effusion lymphoma-like lymphoma: an autopsied case. Ann Hematol. 2011;90:219-220.
35. Wang T, Nava VE, Schechter GP, et al. Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma: a patient successfully treated with pleurodesis. J Clin Oncol. 2011;29: e747-e750.
36. Terasaki Y, Yamamoto H, Kiyokawa H, et al. Disappearance of malignant cells by effusion drainage alone in two patients with HHV-8-unrelated HIV-negative primary effusion lymphoma-like lymphoma. Int J Hematol. 2011;94:279-284.
37. Kobayashi Y, Kamitsuji Y, Kuroda J, et al. Comparison of human herpes virus 8 related primary effusion lymphoma with human herpes virus 8 unrelated primary effusion lymphoma-like lymphoma on the basis of HIV: report of 2 cases and review of 212 cases in the literature. Acta Haematol. 2007;117:132-144.
38. Carbone A, Gloghini A. PEL and HHV8-unrelated effusion lymphoma. Classification and diagnosis. Cancer. 2008;114:225-227.
39. Chan JKC, Aozasa K, Gaulard P. DLBCL associated with chronic inflammation. In: Swerdlow S, Campo E, Harris N, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC WHO Classification of Tumours; 2008:245-246.
40. Imai Y, Oshawa M, Tanaka H, et al. High prevalence of HCV infection in patients with B-cell non-Hodgkin's lymphoma: comparison with birth cohort-and sex-matched blood donors in a Japanese population. Hepatology. 2002;35:974-976.
41. Vallisa D, Berte R, Rocca A, et al. Association between hepatitis C virus and non-Hodgkin's lymphoma, and effects of viral infection on histologic subtype and clinical course. Am JMed. 1999;106:556-560.
42. Franzin F, Efremov DG, Pozzato G, et al. Clonal B-cell expansion in peripheral blood of HCV-infected patients. Br J Haematol. 1995; 90:548-552.
43. Lerat H, Rumin S, Habersetzer F. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood. 1998;91:3841-3849.
44. Chak E, Talal AH, Sherman KE, et al. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int. 2011;31:1090-1101.